Abvc Biopharma, Inc. (ABVC) — DEF 14A Filings
All DEF 14A filings from Abvc Biopharma, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
ABVC Biopharma Files Definitive Proxy Statement
— May 16, 2025 Risk: medium
ABVC Biopharma, Inc. filed its Definitive Proxy Statement (DEF 14A) on May 16, 2025, for its annual meeting on June 3, 2025. The filing details the company's go
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX